Navigation Links
Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
Date:3/10/2011

arch agreements

--500,000100,000Total revenues

156,352208,6521,480,362892,644Operating expenses:Research and development

6,940,5647,573,25132,797,67234,416,983Marketing

1,995,716194,8335,051,0061,049,760General and administrative

3,710,7392,074,19212,499,8778,024,138Total operating expenses

12,647,0199,842,27650,348,55543,490,881Loss from operations

(12,490,667)(9,633,624)(48,868,193)(42,598,237)Interest income and other, net

227,89955,025329,290363,998Consolidated net loss

$(12,262,768)$ (9,578,599)$(48,538,903)$(42,234,239)Net loss attributable to noncontrolling interest

316,766141,6821,199,161141,682 Net loss attributable to Optimer Pharmaceuticals, Inc. common stockholders

$(11,946,002)$ (9,436,917)$(47,339,742)$(42,092,557)Basic and diluted net loss per share attributable to common stockholders

$
(0.31)$
(0.28)$
(1.25)$
(1.30)Shares used to compute basic and diluted net  loss per share attributable to common stockholders

39,140,21433,117,09537,830,45232,468,702Optimer Pharmaceuticals, Inc.Consolidated Balance SheetsYear Ended December 31,20102009ASSETSCurrent assets:Cash and cash equivalents

$  19,861,924$ 17,054,328Short-term investments

29,553,50621,131,145Prepaid expenses and other current assets

516,859416,859Total current assets

49,932,28938,602,332Property and equipment, net

697,683672,896Long-term investments

882,000882,000Other assets

508,190498,762Total assets

$  52,020,162$ 40,655,990LIABILITIES  AND STOCKHOLDERS'  EQUITYCurrent liabilities:Accounts payable

$
2,307,820$   2,625,240Accrued expenses

2,385,0465,025,669Total current liabilities

$
4,692,866$   7,650,909Deferred rent

141,138253,474Commitments and contingencies

--Stockholders’ equity

47,186,15832,751,607Total liabilities and stockholders’ e
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
8. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
9. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
10. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
11. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Virginia , 11. Juli 2014 ... von Kameras für die molekulare Bildgebung, ... hat heute die CE-Zulassung für sein ... CE-Zeichen kann Dilon das Produkt jetzt ... auf den Großteil der europäischen Länder ...
(Date:7/10/2014)... -- RESMED INC. (NYSE: RMD ) today announced that ... June 30, 2014 results on Thursday, July 31, 2014, after ... with ResMed,s results will be issued after 1:00 p.m. US ... discuss operating results and future outlook. The earnings ... Time and the live webcast of the call can be ...
(Date:7/10/2014)... 2014   Ventana Medical Systems, Inc.  (Ventana), a ... entered into an agreement with Merck KGaA, Darmstadt, ... in the United States and ... KGaA,s biopharmaceutical division on the development and commercialization of ... Ventana,s proprietary diagnostic assays. In alignment with Merck KGaA,s ...
Breaking Medicine Technology:Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3
... MESA, Ariz., Dec. 6, 2011   Ulthera ... device company pioneering aesthetic and medical applications ... today announced that it has named Greg ... newly created position at Ulthera. ...
... Industries, Inc. (OTC.PK:PDMI) announced that it is continuing to move ... the limited working capital and market concerns it has had ... the mettle of Paradigm, its shareholders and remaining loyal employees. ... close, Paradigm remains hopeful it will see the DTC "chill" ...
Cached Medicine Technology:Ulthera Appoints Greg Waller as Chief Financial Officer 2Paradigm Business Update as of November 30, 2011 2
(Date:7/13/2014)... (PRWEB) July 13, 2014 Chromatography ... biological components from various types of biological samples ... separate the sample mixture into two phase, namely ... the mobile phase run over the stationary phase, ... the components that provide the separation of mixture. ...
(Date:7/13/2014)... 13, 2014 The report “Micronutrient ... Iron), Form (Chelated & Non Chelated), Application Mode ... Global Trends and Forecast to 2018” defines and ... analysis and forecasting of the global value and ... driving and restraining factors for the global agriculture ...
(Date:7/13/2014)... 13, 2014 A Massachusetts couple who ... cancer risks associated with power morcellators ( http://www.gynecaremorcellatorlawsuit.com/ ) ... to federal regulators, as they presented poignant testimony on ... Drug Administration (FDA) advisory panel meeting convened to address ... the Rochester Democrat and Chronicle, Dr. Hooman Noorchashm and ...
(Date:7/13/2014)... Recently, 2014QuinceaneraDresses.com, the distinguished special ... new range of gorgeous Quinceanera dresses . ... for elegant Quinceanera outfits is huge. Therefore, 2014QuinceaneraDresses.com ... the company’s newly released dresses are made according ... elegant and vivid. , It is worthy ...
(Date:7/13/2014)... optical imaging device developed at Cedars-Sinai can provide ... the brain and are a classic sign of ... conducting a clinical trial in Australia. , The ... an oral presentation at the Alzheimer,s Association International ... invited by conference organizers to participate in a ...
Breaking Medicine News(10 mins):Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 2Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 2Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 4Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 2Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 3Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 4Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 3
... the National Institutes of Health (NIH) Clinical Center are ... record, an effort that they hope will lead to ... associated with low-dose radiation exposure from medical imaging tests, ... the Journal of the American College of Radiology ...
... , BOYNTON ... the Move, located in Boynton Beach, Florida , ... system highlighting the positive experiences of women and their many passions. ... to promote the sharing of ideas, advice, and support through various ...
... ... been provided by MAP, International for the relief effort in Haiti. , ... Brunswick, GA (PRWEB) January 31, 2010 ... valued at $10 million dollars committed to the relief effort in Haiti. Much of ...
... gather opinions from others, survey finds , FRIDAY, Jan. 29 ... a reputation for being less likely than women to ask ... may hold true when men go shopping. , In ... and female wine consumers who were purchasing wine for themselves ...
... ... program, nonprofit Community Food & Outreach Center is offering their volunteers a free day at ... ... Day, Get a Disney Day” program announced on September 29, 2009, Community Food and Outreach ...
... ... toll road cutting in half the time it takes to get to the Pacific ... years in the making is now completely operational. Here is a story of ... reputation of Costa Rica,s highway system. This is a huge boom to Pacific ...
Cached Medicine News:Health News:NIH takes step to assess any possible risk associated with low-dose radiation exposure 2Health News:Leslie Harris...Woman On The Move! 2Health News:Leslie Harris...Woman On The Move! 3Health News:MAP International Provides $10 Million in Essential Medicines and Medical Supplies to Haiti Relief 2Health News:Men Likely to Research a Purchase, Not Ask for Advice 2Health News:Volunteers at Community Food & Outreach Center Get a Day at Disney 2Health News:After 31 Years, the New San Jose Caldera Highway is Now Fully Operational in Costa Rica 2Health News:After 31 Years, the New San Jose Caldera Highway is Now Fully Operational in Costa Rica 3
Contains the most common procedures from all orthopedic sub-specialties organized by body area....
Athouritative, on the spot answers for acute care and consultations....
Product includes all 15 Lexi-Comps databases. Includes Lexi-drugs, the official reference of the American Pharmacists Association and the National Professional Society of Pharmacists....
... Safety Knife with BD Xstar Blade includes ... protects the blade in prodedure and handling. ... on a grind-less process for manufacturing surgical ... sharpness and consistency. The arch style, ...
Medicine Products: